nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—Leflunomide—rheumatoid arthritis	0.59	1	CrCtD
Niflumic Acid—PLA2G1B—Sulfasalazine—rheumatoid arthritis	0.0991	0.34	CbGbCtD
Niflumic Acid—PLA2G1B—Betamethasone—rheumatoid arthritis	0.085	0.292	CbGbCtD
Niflumic Acid—PTGS2—rheumatoid arthritis	0.0763	1	CbGaD
Niflumic Acid—PLA2G1B—Dexamethasone—rheumatoid arthritis	0.0495	0.17	CbGbCtD
Niflumic Acid—SLC16A1—Methotrexate—rheumatoid arthritis	0.0146	0.0501	CbGbCtD
Niflumic Acid—PTGS2—Sulfasalazine—rheumatoid arthritis	0.0103	0.0353	CbGbCtD
Niflumic Acid—PTGS2—Triamcinolone—rheumatoid arthritis	0.0103	0.0353	CbGbCtD
Niflumic Acid—PTGS2—Betamethasone—rheumatoid arthritis	0.00882	0.0303	CbGbCtD
Niflumic Acid—PTGS1—Sulfasalazine—rheumatoid arthritis	0.00868	0.0298	CbGbCtD
Niflumic Acid—PTGS2—Dexamethasone—rheumatoid arthritis	0.00513	0.0176	CbGbCtD
Niflumic Acid—PLA2G1B—exocrine gland—rheumatoid arthritis	0.00143	0.146	CbGeAlD
Niflumic Acid—Leflunomide—AHR—rheumatoid arthritis	0.00138	0.82	CrCbGaD
Niflumic Acid—CLCNKA—digestive system—rheumatoid arthritis	0.0012	0.122	CbGeAlD
Niflumic Acid—PTGS2—skeletal joint—rheumatoid arthritis	0.000903	0.0918	CbGeAlD
Niflumic Acid—PTGS2—synovial membrane of synovial joint—rheumatoid arthritis	0.000686	0.0697	CbGeAlD
Niflumic Acid—PLA2G1B—connective tissue—rheumatoid arthritis	0.000657	0.0668	CbGeAlD
Niflumic Acid—PTGS2—cartilage tissue—rheumatoid arthritis	0.000607	0.0617	CbGeAlD
Niflumic Acid—SLC16A7—saliva-secreting gland—rheumatoid arthritis	0.000602	0.0612	CbGeAlD
Niflumic Acid—PLA2G1B—digestive system—rheumatoid arthritis	0.000474	0.0482	CbGeAlD
Niflumic Acid—PLA2G4A—saliva-secreting gland—rheumatoid arthritis	0.000435	0.0442	CbGeAlD
Niflumic Acid—UGT1A9—digestive system—rheumatoid arthritis	0.000434	0.0441	CbGeAlD
Niflumic Acid—PLA2G4A—connective tissue—rheumatoid arthritis	0.0004	0.0407	CbGeAlD
Niflumic Acid—PLA2G4A—Raltitrexed—Methotrexate—rheumatoid arthritis	0.000396	0.266	CbGdCrCtD
Niflumic Acid—SLC16A7—tendon—rheumatoid arthritis	0.00038	0.0387	CbGeAlD
Niflumic Acid—PLA2G4A—tendon—rheumatoid arthritis	0.000275	0.0279	CbGeAlD
Niflumic Acid—SLC16A1—digestive system—rheumatoid arthritis	0.000254	0.0259	CbGeAlD
Niflumic Acid—SLC16A1—tendon—rheumatoid arthritis	0.000242	0.0246	CbGeAlD
Niflumic Acid—Floctafenine—PTGS2—rheumatoid arthritis	0.000218	0.13	CrCbGaD
Niflumic Acid—PTGS1—connective tissue—rheumatoid arthritis	0.000158	0.0161	CbGeAlD
Niflumic Acid—PTGS2—connective tissue—rheumatoid arthritis	0.000151	0.0153	CbGeAlD
Niflumic Acid—PTGS1—digestive system—rheumatoid arthritis	0.000114	0.0116	CbGeAlD
Niflumic Acid—PTGS2—lymphoid tissue—rheumatoid arthritis	0.00011	0.0112	CbGeAlD
Niflumic Acid—PTGS2—Fluocinonide—Methylprednisolone—rheumatoid arthritis	0.00011	0.0736	CbGdCrCtD
Niflumic Acid—PTGS2—digestive system—rheumatoid arthritis	0.000109	0.0111	CbGeAlD
Niflumic Acid—PTGS1—tendon—rheumatoid arthritis	0.000109	0.011	CbGeAlD
Niflumic Acid—PTGS2—Fluocinonide—Dexamethasone—rheumatoid arthritis	0.000108	0.0725	CbGdCrCtD
Niflumic Acid—PTGS2—Fluocinonide—Betamethasone—rheumatoid arthritis	0.000108	0.0725	CbGdCrCtD
Niflumic Acid—PTGS2—Fluocinonide—Triamcinolone—rheumatoid arthritis	0.000105	0.0708	CbGdCrCtD
Niflumic Acid—PTGS2—tendon—rheumatoid arthritis	0.000104	0.0105	CbGeAlD
Niflumic Acid—Mefenamic acid—PTGS2—rheumatoid arthritis	8.53e-05	0.0506	CrCbGaD
Niflumic Acid—PTGS2—Fluticasone Propionate—Methylprednisolone—rheumatoid arthritis	6.62e-05	0.0444	CbGdCrCtD
Niflumic Acid—PTGS2—Fluticasone Propionate—Betamethasone—rheumatoid arthritis	6.52e-05	0.0437	CbGdCrCtD
Niflumic Acid—PTGS2—Fluticasone Propionate—Dexamethasone—rheumatoid arthritis	6.52e-05	0.0437	CbGdCrCtD
Niflumic Acid—PTGS2—Fluticasone Propionate—Triamcinolone—rheumatoid arthritis	6.37e-05	0.0427	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Hydrocortisone—rheumatoid arthritis	3.67e-05	0.0246	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Hydrocortisone—rheumatoid arthritis	3.67e-05	0.0246	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Methylprednisolone—rheumatoid arthritis	3.46e-05	0.0232	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Methylprednisolone—rheumatoid arthritis	3.46e-05	0.0232	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Dexamethasone—rheumatoid arthritis	3.4e-05	0.0229	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Betamethasone—rheumatoid arthritis	3.4e-05	0.0229	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Triamcinolone—rheumatoid arthritis	3.33e-05	0.0223	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Triamcinolone—rheumatoid arthritis	3.33e-05	0.0223	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Prednisone—rheumatoid arthritis	3.16e-05	0.0212	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Prednisone—rheumatoid arthritis	3.16e-05	0.0212	CbGdCrCtD
Niflumic Acid—PLA2G4A—Betamethasone—Prednisolone—rheumatoid arthritis	3.08e-05	0.0207	CbGdCrCtD
Niflumic Acid—PLA2G4A—Dexamethasone—Prednisolone—rheumatoid arthritis	3.08e-05	0.0207	CbGdCrCtD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—TNF—rheumatoid arthritis	1.45e-05	0.000497	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—C5—rheumatoid arthritis	1.44e-05	0.000494	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—PTK2—rheumatoid arthritis	1.43e-05	0.000488	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—BGN—rheumatoid arthritis	1.43e-05	0.000487	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—IL2—rheumatoid arthritis	1.41e-05	0.000483	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IFNG—rheumatoid arthritis	1.41e-05	0.000482	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—FN1—rheumatoid arthritis	1.39e-05	0.000476	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—SLC25A12—rheumatoid arthritis	1.38e-05	0.000473	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—CSF2—rheumatoid arthritis	1.38e-05	0.000471	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—NOS2—rheumatoid arthritis	1.37e-05	0.00047	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CCR6—rheumatoid arthritis	1.36e-05	0.000464	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	1.35e-05	0.000461	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTGES—rheumatoid arthritis	1.35e-05	0.00046	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GC—rheumatoid arthritis	1.35e-05	0.00046	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MED1—rheumatoid arthritis	1.32e-05	0.000453	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PDE2A—rheumatoid arthritis	1.32e-05	0.000453	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CAT—rheumatoid arthritis	1.32e-05	0.00045	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ALOX5—rheumatoid arthritis	1.31e-05	0.000448	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—CXCL8—rheumatoid arthritis	1.31e-05	0.000448	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SYVN1—rheumatoid arthritis	1.28e-05	0.000436	CbGpPWpGaD
Niflumic Acid—UGT1A9—NRF2 pathway—TGFB1—rheumatoid arthritis	1.27e-05	0.000435	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PLB1—rheumatoid arthritis	1.26e-05	0.000432	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL1B—rheumatoid arthritis	1.26e-05	0.00043	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL2—rheumatoid arthritis	1.25e-05	0.000428	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PLB1—rheumatoid arthritis	1.25e-05	0.000428	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IL2RA—rheumatoid arthritis	1.24e-05	0.000425	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PLD4—rheumatoid arthritis	1.24e-05	0.000425	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CCL3—rheumatoid arthritis	1.24e-05	0.000424	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCL2—rheumatoid arthritis	1.24e-05	0.000424	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	1.24e-05	0.000424	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ACP5—rheumatoid arthritis	1.23e-05	0.000421	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—B3GNT2—rheumatoid arthritis	1.23e-05	0.000421	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	1.23e-05	0.00042	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—SAA1—rheumatoid arthritis	1.21e-05	0.000415	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—rheumatoid arthritis	1.2e-05	0.000411	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ACAN—rheumatoid arthritis	1.2e-05	0.00041	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—MMP1—rheumatoid arthritis	1.19e-05	0.000405	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—MMP9—rheumatoid arthritis	1.19e-05	0.000405	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—IL6—rheumatoid arthritis	1.17e-05	0.000401	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RBPJ—rheumatoid arthritis	1.17e-05	0.000398	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	1.16e-05	0.000395	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—ALB—rheumatoid arthritis	1.16e-05	0.000395	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—TNF—rheumatoid arthritis	1.15e-05	0.000394	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ACAN—rheumatoid arthritis	1.14e-05	0.000389	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—SLC25A12—rheumatoid arthritis	1.13e-05	0.000386	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—BGN—rheumatoid arthritis	1.11e-05	0.000379	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—NOS3—rheumatoid arthritis	1.11e-05	0.000378	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—rheumatoid arthritis	1.1e-05	0.000377	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—MTHFR—rheumatoid arthritis	1.1e-05	0.000375	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MED1—rheumatoid arthritis	1.1e-05	0.000375	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GC—rheumatoid arthritis	1.1e-05	0.000375	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTGES—rheumatoid arthritis	1.1e-05	0.000375	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—FN1—rheumatoid arthritis	1.08e-05	0.00037	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ENO1—rheumatoid arthritis	1.07e-05	0.000366	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SLC25A12—rheumatoid arthritis	1.07e-05	0.000366	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—NOS2—rheumatoid arthritis	1.07e-05	0.000365	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—BDKRB2—rheumatoid arthritis	1.06e-05	0.000361	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCL12—rheumatoid arthritis	1.06e-05	0.000361	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—ADRBK1—rheumatoid arthritis	1.04e-05	0.000357	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCL13—rheumatoid arthritis	1.03e-05	0.000352	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PLB1—rheumatoid arthritis	1.02e-05	0.000349	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—B3GNT2—rheumatoid arthritis	1.02e-05	0.000349	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ALOX5—rheumatoid arthritis	1.02e-05	0.000349	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ACP5—rheumatoid arthritis	1.02e-05	0.000349	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	1.02e-05	0.000349	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	1e-05	0.000342	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PLD4—rheumatoid arthritis	9.86e-06	0.000337	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—RASGRP1—rheumatoid arthritis	9.85e-06	0.000337	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TGFB1—rheumatoid arthritis	9.77e-06	0.000334	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PLB1—rheumatoid arthritis	9.67e-06	0.000331	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PRKCQ—rheumatoid arthritis	9.64e-06	0.000329	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ACAN—rheumatoid arthritis	9.53e-06	0.000326	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—IL2—rheumatoid arthritis	9.37e-06	0.00032	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCL10—rheumatoid arthritis	9.33e-06	0.000319	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—IL6—rheumatoid arthritis	9.31e-06	0.000318	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IRAK1—rheumatoid arthritis	9.27e-06	0.000317	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TLE3—rheumatoid arthritis	9.27e-06	0.000317	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—BGN—rheumatoid arthritis	9.19e-06	0.000314	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CX3CR1—rheumatoid arthritis	9.18e-06	0.000314	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TNF—rheumatoid arthritis	9.12e-06	0.000312	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—ALB—rheumatoid arthritis	8.99e-06	0.000307	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	8.97e-06	0.000307	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SLC25A12—rheumatoid arthritis	8.96e-06	0.000306	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MED1—rheumatoid arthritis	8.95e-06	0.000306	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—RBPJ—rheumatoid arthritis	8.93e-06	0.000305	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL2RB—rheumatoid arthritis	8.83e-06	0.000302	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—POMC—rheumatoid arthritis	8.78e-06	0.0003	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PTGES—rheumatoid arthritis	8.71e-06	0.000298	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GC—rheumatoid arthritis	8.71e-06	0.000298	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—NOS3—rheumatoid arthritis	8.59e-06	0.000294	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—C5—rheumatoid arthritis	8.53e-06	0.000292	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—MMP3—rheumatoid arthritis	8.51e-06	0.000291	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ALOX5—rheumatoid arthritis	8.45e-06	0.000289	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NFATC1—rheumatoid arthritis	8.39e-06	0.000287	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—B3GNT2—rheumatoid arthritis	8.32e-06	0.000284	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ACP5—rheumatoid arthritis	8.32e-06	0.000284	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ENO1—rheumatoid arthritis	8.32e-06	0.000284	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	8.18e-06	0.00028	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PLB1—rheumatoid arthritis	8.1e-06	0.000277	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TP53—rheumatoid arthritis	8.04e-06	0.000275	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CCL5—rheumatoid arthritis	8.03e-06	0.000275	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCR6—rheumatoid arthritis	8.02e-06	0.000274	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—ALB—rheumatoid arthritis	8.01e-06	0.000274	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	7.98e-06	0.000273	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—VEGFA—rheumatoid arthritis	7.96e-06	0.000272	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CSF2—rheumatoid arthritis	7.91e-06	0.00027	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—B3GNT2—rheumatoid arthritis	7.88e-06	0.000269	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ACP5—rheumatoid arthritis	7.88e-06	0.000269	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	7.84e-06	0.000268	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NCF2—rheumatoid arthritis	7.8e-06	0.000267	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CAT—rheumatoid arthritis	7.7e-06	0.000263	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—NOS3—rheumatoid arthritis	7.66e-06	0.000262	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SH2B3—rheumatoid arthritis	7.6e-06	0.00026	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TRAF6—rheumatoid arthritis	7.6e-06	0.00026	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GZMB—rheumatoid arthritis	7.56e-06	0.000258	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—BGN—rheumatoid arthritis	7.49e-06	0.000256	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	7.43e-06	0.000254	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL6—rheumatoid arthritis	7.36e-06	0.000252	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCL3—rheumatoid arthritis	7.34e-06	0.000251	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCL2—rheumatoid arthritis	7.34e-06	0.000251	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TGFB1—rheumatoid arthritis	7.31e-06	0.00025	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IL2—rheumatoid arthritis	7.29e-06	0.000249	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	7.24e-06	0.000247	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CCR5—rheumatoid arthritis	7.24e-06	0.000247	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SAA1—rheumatoid arthritis	7.17e-06	0.000245	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	7.16e-06	0.000245	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL2RA—rheumatoid arthritis	7.13e-06	0.000244	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MED1—rheumatoid arthritis	7.1e-06	0.000243	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—BGN—rheumatoid arthritis	7.1e-06	0.000243	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TLE3—rheumatoid arthritis	7.1e-06	0.000243	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—C3—rheumatoid arthritis	7.07e-06	0.000242	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NCF1—rheumatoid arthritis	7.03e-06	0.00024	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTGS2—rheumatoid arthritis	7e-06	0.000239	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ENO1—rheumatoid arthritis	6.89e-06	0.000236	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ALOX5—rheumatoid arthritis	6.89e-06	0.000236	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	6.78e-06	0.000232	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CD28—rheumatoid arthritis	6.76e-06	0.000231	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	6.64e-06	0.000227	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ACP5—rheumatoid arthritis	6.6e-06	0.000226	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—B3GNT2—rheumatoid arthritis	6.6e-06	0.000226	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SLC11A1—rheumatoid arthritis	6.48e-06	0.000221	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NFATC1—rheumatoid arthritis	6.43e-06	0.00022	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—MTHFR—rheumatoid arthritis	6.42e-06	0.00022	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—UBE2D1—rheumatoid arthritis	6.36e-06	0.000217	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCL12—rheumatoid arthritis	6.24e-06	0.000213	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—BDKRB2—rheumatoid arthritis	6.24e-06	0.000213	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	6.2e-06	0.000212	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—VEGFA—rheumatoid arthritis	6.19e-06	0.000212	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL6ST—rheumatoid arthritis	6.18e-06	0.000211	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADRBK1—rheumatoid arthritis	6.17e-06	0.000211	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	6.06e-06	0.000207	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TP53—rheumatoid arthritis	6.02e-06	0.000206	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CAT—rheumatoid arthritis	5.99e-06	0.000205	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NCF2—rheumatoid arthritis	5.97e-06	0.000204	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—BGN—rheumatoid arthritis	5.94e-06	0.000203	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	5.93e-06	0.000203	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RASGRP1—rheumatoid arthritis	5.82e-06	0.000199	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SYK—rheumatoid arthritis	5.8e-06	0.000198	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.69e-06	0.000195	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TGFB1—rheumatoid arthritis	5.68e-06	0.000194	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—POMC—rheumatoid arthritis	5.66e-06	0.000193	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ENO1—rheumatoid arthritis	5.62e-06	0.000192	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—STAT1—rheumatoid arthritis	5.59e-06	0.000191	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CCL2—rheumatoid arthritis	5.53e-06	0.000189	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	5.53e-06	0.000189	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL6R—rheumatoid arthritis	5.52e-06	0.000189	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCL10—rheumatoid arthritis	5.51e-06	0.000188	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SAA1—rheumatoid arthritis	5.49e-06	0.000188	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALOX5—rheumatoid arthritis	5.47e-06	0.000187	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	5.47e-06	0.000187	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NCF1—rheumatoid arthritis	5.38e-06	0.000184	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ENO1—rheumatoid arthritis	5.33e-06	0.000182	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CD28—rheumatoid arthritis	5.17e-06	0.000177	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—POMC—rheumatoid arthritis	5.14e-06	0.000176	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MMP3—rheumatoid arthritis	5.03e-06	0.000172	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—TYK2—rheumatoid arthritis	5.03e-06	0.000172	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MTHFR—rheumatoid arthritis	5e-06	0.000171	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CAT—rheumatoid arthritis	4.96e-06	0.00017	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—UBE2D1—rheumatoid arthritis	4.87e-06	0.000166	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTK2—rheumatoid arthritis	4.84e-06	0.000165	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	4.83e-06	0.000165	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	4.81e-06	0.000164	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCL5—rheumatoid arthritis	4.75e-06	0.000162	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ADRBK1—rheumatoid arthritis	4.72e-06	0.000161	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ALB—rheumatoid arthritis	4.68e-06	0.00016	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TP53—rheumatoid arthritis	4.68e-06	0.00016	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CSF2—rheumatoid arthritis	4.67e-06	0.00016	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—NOS3—rheumatoid arthritis	4.48e-06	0.000153	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ENO1—rheumatoid arthritis	4.46e-06	0.000152	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SPP1—rheumatoid arthritis	4.39e-06	0.00015	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	4.39e-06	0.00015	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.38e-06	0.00015	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PRKCQ—rheumatoid arthritis	4.36e-06	0.000149	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—STAT1—rheumatoid arthritis	4.28e-06	0.000146	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCR5—rheumatoid arthritis	4.28e-06	0.000146	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL2RA—rheumatoid arthritis	4.21e-06	0.000144	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL2—rheumatoid arthritis	4.18e-06	0.000143	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—C3—rheumatoid arthritis	4.18e-06	0.000143	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MTHFR—rheumatoid arthritis	4.14e-06	0.000142	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTGS2—rheumatoid arthritis	4.1e-06	0.00014	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CAT—rheumatoid arthritis	4.04e-06	0.000138	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—POMC—rheumatoid arthritis	4e-06	0.000137	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LEP—rheumatoid arthritis	3.89e-06	0.000133	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FN1—rheumatoid arthritis	3.67e-06	0.000125	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL6ST—rheumatoid arthritis	3.65e-06	0.000125	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ALB—rheumatoid arthritis	3.64e-06	0.000125	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CD80—rheumatoid arthritis	3.52e-06	0.00012	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NOS3—rheumatoid arthritis	3.48e-06	0.000119	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MTHFR—rheumatoid arthritis	3.37e-06	0.000115	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—POMC—rheumatoid arthritis	3.34e-06	0.000114	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—POMC—rheumatoid arthritis	3.31e-06	0.000113	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CCR5—rheumatoid arthritis	3.27e-06	0.000112	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCL2—rheumatoid arthritis	3.27e-06	0.000112	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL6R—rheumatoid arthritis	3.26e-06	0.000111	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CAT—rheumatoid arthritis	3.21e-06	0.00011	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MTHFR—rheumatoid arthritis	3.2e-06	0.000109	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HLA-A—rheumatoid arthritis	3.19e-06	0.000109	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTGS2—rheumatoid arthritis	3.19e-06	0.000109	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ALB—rheumatoid arthritis	3.02e-06	0.000103	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TYK2—rheumatoid arthritis	2.97e-06	0.000101	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NOS3—rheumatoid arthritis	2.91e-06	9.96e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NOS3—rheumatoid arthritis	2.89e-06	9.87e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IL6ST—rheumatoid arthritis	2.8e-06	9.56e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS2—rheumatoid arthritis	2.78e-06	9.49e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—POMC—rheumatoid arthritis	2.7e-06	9.23e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CD80—rheumatoid arthritis	2.69e-06	9.2e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MTHFR—rheumatoid arthritis	2.68e-06	9.16e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTGS2—rheumatoid arthritis	2.64e-06	9.03e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCL8—rheumatoid arthritis	2.58e-06	8.83e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IL6R—rheumatoid arthritis	2.5e-06	8.53e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL2—rheumatoid arthritis	2.47e-06	8.44e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ALB—rheumatoid arthritis	2.46e-06	8.41e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL6—rheumatoid arthritis	2.46e-06	8.4e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NOS3—rheumatoid arthritis	2.35e-06	8.05e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MMP9—rheumatoid arthritis	2.34e-06	7.99e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NFKB1—rheumatoid arthritis	2.31e-06	7.91e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MAPK8—rheumatoid arthritis	2.27e-06	7.77e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TYK2—rheumatoid arthritis	2.27e-06	7.77e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS3—rheumatoid arthritis	2.23e-06	7.63e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTGS2—rheumatoid arthritis	2.15e-06	7.36e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—POMC—rheumatoid arthritis	2.14e-06	7.32e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—VEGFA—rheumatoid arthritis	2.1e-06	7.18e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CD4—rheumatoid arthritis	2.06e-06	7.03e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALB—rheumatoid arthritis	1.95e-06	6.68e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TGFB1—rheumatoid arthritis	1.93e-06	6.59e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NOS3—rheumatoid arthritis	1.87e-06	6.39e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TP53—rheumatoid arthritis	1.59e-06	5.42e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TGFB1—rheumatoid arthritis	1.48e-06	5.04e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL6—rheumatoid arthritis	1.45e-06	4.96e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IL6—rheumatoid arthritis	1.11e-06	3.8e-05	CbGpPWpGaD
